Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Farnaz Tabatabaian & Thomas B Casale. (2018) Allergic rhinitis management: what’s next?. Expert Review of Clinical Immunology 14:3, pages 191-196.
Read now
Read now
Peter A. Ricketti, Sultan Alandijani, Chen Hsing Lin & Thomas B. Casale. (2017) Investigational new drugs for allergic rhinitis. Expert Opinion on Investigational Drugs 26:3, pages 279-292.
Read now
Read now
Sarang Tartey & Osamu Takeuchi. (2017) Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells. International Reviews of Immunology 36:2, pages 57-73.
Read now
Read now
Ludger Klimek, Joaquim Mullol, Peter Hellings, Philippe Gevaert, Ralph Mösges & Wytske Fokkens. (2016) Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis. Expert Opinion on Pharmacotherapy 17:5, pages 657-669.
Read now
Read now
Clare E. Bryant, Nick J. Gay, Stephane Heymans, Sandra Sacre, Liliana Schaefer & Kim S. Midwood. (2015) Advances in Toll-like receptor biology: Modes of activation by diverse stimuli. Critical Reviews in Biochemistry and Molecular Biology 50:5, pages 359-379.
Read now
Read now
Alessandra Sandrini, Jennifer M Rolland & Robyn E O’Hehir. (2015) Current developments for improving efficacy of allergy vaccines. Expert Review of Vaccines 14:8, pages 1073-1087.
Read now
Read now
Erminia Ridolo, Marcello Montagni, Valerie Melli, Fulvio Braido, Cristoforo Incorvaia & Giorgio Walter Canonica. (2014) Pharmacotherapy of allergic rhinitis: current options and future perspectives. Expert Opinion on Pharmacotherapy 15:1, pages 73-83.
Read now
Read now
Articles from other publishers (40)
Hui Li, Shi‐En Huang, Cong‐Li Geng, Yu‐Xiao Wu, Mu‐Han Shi & Min Wang. (2023) Comprehensive analysis reveals hub genes associated with immune cell infiltration in allergic rhinitis. World Journal of Otorhinolaryngology - Head and Neck Surgery 9:4, pages 340-351.
Crossref
Crossref
Andreas Frey, Lars P. Lunding & Michael Wegmann. (2023) The Dual Role of the Airway Epithelium in Asthma: Active Barrier and Regulator of Inflammation. Cells 12:18, pages 2208.
Crossref
Crossref
Suizi Zhou, Chaozheng Zhou, Xinyue Wang, Peng Luo, Anqi Lin, Yi Cui & Qianhui Qiu. (2023) Profiles of immune infiltration in seasonal allergic rhinitis and related genes and pathways. International Immunopharmacology 120, pages 110174.
Crossref
Crossref
Sarah K. Wise, Cecelia Damask, Lauren T. Roland, Charles Ebert, Joshua M. Levy, Sandra Lin, Amber Luong, Kenneth Rodriguez, Ahmad R. Sedaghat, Elina Toskala, Jennifer Villwock, Baharudin Abdullah, Cezmi Akdis, Jeremiah A. Alt, Ignacio J. Ansotegui, Antoine Azar, Fuad Baroody, Michael S. Benninger, Jonathan Bernstein, Christopher Brook, Raewyn Campbell, Thomas Casale, Mohamad R. Chaaban, Fook Tim Chew, Jeffrey Chambliss, Antonella Cianferoni, Adnan Custovic, Elizabeth Mahoney Davis, John M. DelGaudio, Anne K. Ellis, Carrie Flanagan, Wytske J. Fokkens, Christine Franzese, Matthew Greenhawt, Amarbir Gill, Ashleigh Halderman, Jens M. Hohlfeld, Cristoforo Incorvaia, Stephanie A. Joe, Shyam Joshi, Merin Elizabeth Kuruvilla, Jean Kim, Adam M. Klein, Helene J. Krouse, Edward C. Kuan, David Lang, Desiree Larenas‐Linnemann, Adrienne M. Laury, Matt Lechner, Stella E. Lee, Victoria S. Lee, Patricia Loftus, Sonya Marcus, Haidy Marzouk, Jose Mattos, Edward McCoul, Erik Melen, James W. Mims, Joaquim Mullol, Jayakar V. Nayak, John Oppenheimer, Richard R. Orlandi, Katie Phillips, Michael Platt, Murugappan RamanathanJrJr, Mallory Raymond, Chae‐Seo Rhee, Sietze Reitsma, Matthew Ryan, Joaquin Sastre, Rodney J. Schlosser, Theodore A. Schuman, Marcus S. Shaker, Aziz Sheikh, Kristine A. Smith, Michael B. Soyka, Masayoshi Takashima, Monica Tang, Pongsakorn Tantilipikorn, Malcolm B. Taw, Jody Tversky, Matthew A. Tyler, Maria C. Veling, Dana Wallace, De Yun Wang, Andrew White & Luo Zhang. (2023) International consensus statement on allergy and rhinology: Allergic rhinitis – 2023. International Forum of Allergy & Rhinology 13:4, pages 293-859.
Crossref
Crossref
Ye Peng, Yanzhong Wang, Manling Wang, Jianping Lan & Yirui Chen. (2022) Therapeutic applications of toll-like receptors (TLRs) agonists in AML. Clinical and Translational Oncology 24:12, pages 2319-2329.
Crossref
Crossref
Jae Ik Yu, Ji-Hoon Kim, Ki-El Nam, Wonsik Lee & Dong-Kwon Rhee. (2022)
Pneumococcal Δ
pep27
Immunization Attenuates TLRs and NLRP3 Expression and Relieves Murine Ovalbumin-Induced Allergic Rhinitis
. Journal of Microbiology and Biotechnology 32:6, pages 709-717.
Crossref
Crossref
Xiao Li, Xinyuan Sun, Xuemin Guo, Xueren Li, Shouchun Peng & Xin Mu. (2022) Chemical reagents modulate nucleic acid-activated toll-like receptors. Biomedicine & Pharmacotherapy 147, pages 112622.
Crossref
Crossref
Wonsuck Yoon, Eun-Jae Kim, Yongsung Park, Seunghyun Kim, Yong-Keun Park & Young Yoo. (2021) Bacterially Delivered miRNA-Mediated Toll-like Receptor 8 Gene Silencing for Combined Therapy in a Murine Model of Atopic Dermatitis: Therapeutic Effect of miRTLR8 in AD. Microorganisms 9:8, pages 1715.
Crossref
Crossref
Sachin Bhagchandani, Jeremiah A. Johnson & Darrell J. Irvine. (2021) Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants. Advanced Drug Delivery Reviews 175, pages 113803.
Crossref
Crossref
Naresh Damuka, Kurumurthy Kammari, Angamba Meetei Potshangbam, Anand Kumar Kondapi & Vaibhav Vindal. (2021) Epoxydicoumarin Derivative is a Novel Non‐Nucleoside TLR8 Agonist: Screening, Synthesis and Biological Evaluation. ChemistrySelect 6:24, pages 5941-5948.
Crossref
Crossref
Saghar Pahlavanneshan, Ali Sayadmanesh, Hamidreza Ebrahimiyan & Mohsen Basiri. (2021) Toll-Like Receptor-Based Strategies for Cancer Immunotherapy. Journal of Immunology Research 2021, pages 1-14.
Crossref
Crossref
Ioannis Psallidas, Vibeke Backer, Piotr Kuna, Robert Palmér, Sofia Necander, Malin Aurell, Katarina Korsback, Ziad Taib, Mahdi Hashemi, Per Gustafson, Sara Asimus, Stephen Delaney, Katerina Pardali, Fanyi Jiang, Joachim Almquist, Sam Jackson, Robert L. Coffman, David Keeling & Tariq Sethi. (2021) A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma. American Journal of Respiratory and Critical Care Medicine 203:3, pages 296-306.
Crossref
Crossref
Ali Keshavarz, Atieh Pourbagheri‐Sigaroodi, Parisa Zafari, Nader Bagheri, Seyed H. Ghaffari & Davood Bashash. (2020) Toll‐like receptors (TLRs) in cancer; with an extensive focus on TLR agonists and antagonists. IUBMB Life 73:1, pages 10-25.
Crossref
Crossref
Zixuan Yang, Caiquan Liang, Tianyu Wang, Qingyun Zou, Mengxia Zhou, Yin Cheng, Hu Peng, Zhenhua Ji, Yue Deng, Jianchun Liao & Huanhai Liu. (2020) NLRP3 inflammasome activation promotes the development of allergic rhinitis via epithelium pyroptosis. Biochemical and Biophysical Research Communications 522:1, pages 61-67.
Crossref
Crossref
Declan P. McKernan. 2020. Inflammatory Disorders, Part A. Inflammatory Disorders, Part A
65
109
.
Yongxin Han, Li Zhu, Wei Wu, Hui Zhang, Wei Hu, Liguang Dai & Yanqing Yang. 2020. Regulation of Cancer Immune Checkpoints. Regulation of Cancer Immune Checkpoints
547
618
.
Tim Vierbuchen, Karina Stein & Holger Heine. (2018) RNA is taking its Toll: Impact of RNA‐specific Toll‐like receptors on health and disease. Allergy 74:2, pages 223-235.
Crossref
Crossref
Sam Jackson, Albert F. Candia, Stephen Delaney, Simone Floettmann, Clifford Wong, John D. Campbell, Sariah Kell, Jeremy Lum, Edith M. Hessel, Paula Traquina, Mark McHale, Ian Robinson, John Bell, Rainard Fuhr, David Keeling & Robert L. Coffman. (2018) First-in-Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well-Tolerated. Clinical Pharmacology & Therapeutics 104:2, pages 335-345.
Crossref
Crossref
Sarah K. Wise, Sandra Y. Lin, Elina Toskala, Richard R. Orlandi, Cezmi A. Akdis, Jeremiah A. Alt, Antoine Azar, Fuad M. Baroody, Claus Bachert, G. Walter Canonica, Thomas Chacko, Cemal Cingi, Giorgio Ciprandi, Jacquelynne Corey, Linda S. Cox, Peter Socrates Creticos, Adnan Custovic, Cecelia Damask, Adam DeConde, John M. DelGaudio, Charles S. Ebert, Jean Anderson Eloy, Carrie E. Flanagan, Wytske J. Fokkens, Christine Franzese, Jan Gosepath, Ashleigh Halderman, Robert G. Hamilton, Hans Jürgen Hoffman, Jens M. Hohlfeld, Steven M. Houser, Peter H. Hwang, Cristoforo Incorvaia, Deborah Jarvis, Ayesha N. Khalid, Maritta Kilpeläinen, Todd. T. Kingdom, Helene Krouse, Desiree Larenas-Linnemann, Adrienne M. Laury, Stella E. Lee, Joshua M. Levy, Amber U. Luong, Bradley F. Marple, Edward D. McCoul, K. Christopher McMains, Erik Melén, James W. Mims, Gianna Moscato, Joaquim Mullol, Harold S. Nelson, Monica Patadia, Ruby Pawankar, Oliver Pfaar, Michael P. Platt, William Reisacher, Carmen Rondón, Luke Rudmik, Matthew Ryan, Joaquin Sastre, Rodney J. Schlosser, Russell A. Settipane, Hemant P. Sharma, Aziz Sheikh, Timothy L. Smith, Pongsakorn Tantilipikorn, Jody R. Tversky, Maria C. Veling, De Yun Wang, Marit Westman, Magnus Wickman & Mark Zacharek. (2018) International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis. International Forum of Allergy & Rhinology 8:2, pages 108-352.
Crossref
Crossref
M. R. Edwards, R. P. Walton, D. J. Jackson, W. Feleszko, C. Skevaki, T. Jartti, H. Makrinoti, A. Nikonova, I. P. Shilovskiy, J. Schwarze, S. L. Johnston & M. R. Khaitov. (2017) The potential of anti‐infectives and immunomodulators as therapies for asthma and asthma exacerbations. Allergy 73:1, pages 50-63.
Crossref
Crossref
A. K. Ellis, D. C. Tsitoura, D. Quint, W. Powley & L. A. Lee. (2017) Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial. Clinical & Experimental Allergy 47:9, pages 1193-1203.
Crossref
Crossref
Oscar Palomares, Mübeccel Akdis, Mar Martín‐Fontecha & Cezmi A. Akdis. (2017) Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunological Reviews 278:1, pages 219-236.
Crossref
Crossref
Pavol Surda & Wytske J. Fokkens. (2016) Novel, Alternative, and Controversial Therapies of Rhinitis. Immunology and Allergy Clinics of North America 36:2, pages 401-423.
Crossref
Crossref
Keith BiggadikeMahbub AhmedDoug I. BallDiane M. CoeDeidre A. Dalmas Wilk, Chris D. EdwardsBob H. GibbonCharlotte J. HardyStephen A. HermitageJoanne O. HesseyAimee E. Hillegas, Stephen C. HughesLinos LazaridesXiao Q. LewellAmanda LucasDavid N. MallettMark A. PriceFiona M. PriestDiana J. QuintPoonam ShahAnesh SitaramStephen A. SmithRichard StockerNaimisha A. TrivediDaphne C. TsitouraVictoria Weller. (2016)
Discovery of 6-Amino-2-{[(1
S
)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8
H
-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma
. Journal of Medicinal Chemistry 59:5, pages 1711-1726.
Crossref
Crossref
Christopher M. Royer, Karin Rudolph, Gregory N. Dietsch, Robert M. Hershberg & Edward G. Barrett. (2015) VTX‐1463, a novel TLR‐8 agonist, attenuates nasal congestion after ragweed challenge in sensitized beagle dogs. Immunity, Inflammation and Disease 4:1, pages 45-51.
Crossref
Crossref
Zahra Aryan & Nima Rezaei. (2015) Toll-like receptors as targets for allergen immunotherapy. Current Opinion in Allergy & Clinical Immunology 15:6, pages 568-574.
Crossref
Crossref
D Tsitoura, C Ambery, M Price, W Powley, S Garthside, K Biggadike & D Quint. (2015) Early clinical evaluation of the intranasal TLR7 agonist GSK2245035: Use of translational biomarkers to guide dosing and confirm target engagement. Clinical Pharmacology & Therapeutics 98:4, pages 369-380.
Crossref
Crossref
Michael Platt. (2014) Pharmacotherapy for allergic rhinitis. International Forum of Allergy & Rhinology 4:S2, pages S35-S40.
Crossref
Crossref
Willem van de Veen & M?beccel Akdis. (2014) New Targets for Immune Modulation in Asthma. Current Treatment Options in Allergy 1:2, pages 171-185.
Crossref
Crossref
Thomas B. Casale & Jeffrey R. Stokes. (2014) Immunotherapy: What lies beyond. Journal of Allergy and Clinical Immunology 133:3, pages 612-619.
Crossref
Crossref
Sara Harsini, Maani Beigy, Mahsa Akhavan-Sabbagh & Nima Rezaei. (2014) Toll-like receptors in lymphoid malignancies: Double-edged sword. Critical Reviews in Oncology/Hematology 89:2, pages 262-283.
Crossref
Crossref
Zahra Aryan, Stephen T. Holgate, Danuta Radzioch & Nima Rezaei. (2014) A New Era of Targeting the Ancient Gatekeepers of the Immune System: Toll-Like Agonists in the Treatment of Allergic Rhinitis and Asthma. International Archives of Allergy and Immunology 164:1, pages 46-63.
Crossref
Crossref
Willem A. Velema, Marco van der Toorn, Wiktor Szymanski & Ben L. Feringa. (2013) Design, Synthesis, and Inhibitory Activity of Potent, Photoswitchable Mast Cell Activation Inhibitors. Journal of Medicinal Chemistry 56:11, pages 4456-4464.
Crossref
Crossref
Ofer Levy, Stanislas Goriely & Tobias R. Kollmann. (2013) Immune response to vaccine adjuvants during the first year of life. Vaccine 31:21, pages 2500-2505.
Crossref
Crossref
Ourania Koltsida, Sergey Karamnov, Katerina Pyrillou, Thad Vickery, Aikaterini‐Dimitra Chairakaki, Constantin Tamvakopoulos, Paschalis Sideras, Charles N. Serhan & Evangelos Andreakos. (2013) Toll‐like receptor 7 stimulates production of specialized pro‐resolving lipid mediators and promotes resolution of airway inflammation. EMBO Molecular Medicine 5:5, pages 762-775.
Crossref
Crossref
David J. Dowling, Zhen Tan, Zofia M. Prokopowicz, Christine D. Palmer, Maura-Ann H. Matthews, Gregory N. Dietsch, Robert M. Hershberg & Ofer Levy. (2013) The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult Leukocytes. PLoS ONE 8:3, pages e58164.
Crossref
Crossref
Jorge L Cervantes, Bennett Weinerman, Chaitali Basole & Juan C Salazar. (2012) TLR8: the forgotten relative revindicated. Cellular & Molecular Immunology 9:6, pages 434-438.
Crossref
Crossref
Soroush T. SarvestaniBryan R.G. WilliamsMichael P. Gantier. (2012) Human Toll-Like Receptor 8 Can Be Cool Too: Implications for Foreign RNA Sensing. Journal of Interferon & Cytokine Research 32:8, pages 350-361.
Crossref
Crossref
Dympna J Connolly & Luke AJ O’Neill. (2012) New developments in Toll-like receptor targeted therapeutics. Current Opinion in Pharmacology 12:4, pages 510-518.
Crossref
Crossref
E. Mercier, I.R. Peters, M.J. Day, C. Clercx & D. Peeters. (2012) Toll- and NOD-like receptor mRNA expression in canine sino-nasal aspergillosis and idiopathic lymphoplasmacytic rhinitis. Veterinary Immunology and Immunopathology 145:3-4, pages 618-624.
Crossref
Crossref